SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:
Partnership expands access to high-quality, affordable adolescent and children's behavioral health services SEATTLE , Feb. 27, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that B
This week brought another blow for reproductive rights in the U.S. An Alabama Supreme Court handed down a ruling that not only can frozen embryos be classified as “children,” but destroying them c
Here is how Accolade (ACCD) and Palantir Technologies Inc. (PLTR) have performed compared to their sector so far this year.
The consensus price target hints at a 25.6% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Invest in stocks such as AxoGen (AXGN), Western Digital (WDC), Accolade (ACCD) and Credo Technology (CRDO) for superb earnings acceleration.
Kindbody partnership builds on Accolade's commitment to offer best-in-class women's health, fertility and family-forming capabilities for customers and members SEATTLE , Jan. 23, 2024 /PRNewswire/ --�
LITTLE ROCK, Ark.--(BUSINESS WIRE)--Technology and consumer electronics website CNET has bestowed its “Best of” accolade on Kinetic as the “Best for Fast DSL Internet Speeds.” This is the seco
The consensus price target hints at a 26.9% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Accolade (ACCD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
I continue to recommend a buy rating with a projected 20% growth in FY25. Recent results show that Accolade beat consensus estimates for revenue and EBITDA, and management expects 20% revenue growth a
SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:
Here is how Accolade (ACCD) and Adecco SA (AHEXY) have performed compared to their sector so far this year.
SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35th A
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stephen Annual Inves
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE